Journal of Infertility and Reproductive Biology

ISSN: 2310-7588

The latest research in infertility and reproductive medicine from across the world

Comparison of Estrogen and/or Progesterone on the Oxidative Status in Different Female Cancer Cells

Published date:Dec 20 2024

Journal Title: Journal of Infertility and Reproductive Biology

Issue title: Journal of Infertility and Reproductive Biology: Volume 12, Issue 4

Pages:4 - 14

DOI: 10.18502/jirb.v12i4.17974

Authors:

Neda MohammadiBiochemistry Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz

Asma NeisyBiochemistry Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz

Alireza KarimzadehBiotechnology expert, Zand Institute of Higher Education, Shiraz

Sina VakiliInfertility Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz

Fatemeh Zalfatemehzal@yahoo.comBiochemistry Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz

Abstract:

Background: Oxidative stress has a key role in the development of most types of cancers. Among all the conditions which affect the antioxidant defenses, the effect of using oral contraception pills (OCP) or sex hormone therapy in women during menopause is still an unsolved issue.

Objectives: In the present study, the effect of estrogen (EST) alone, progesterone (PRO) alone and EST+PRO together on oxidative status in HeLa, MCF-7 and OVCAR-3 cell lines was investigated.

Methods: HeLa, MCF- 7 and OVCAR-3 cell lines were treated with 1μM of EST, PRO and EST+PRO confirmed by MTT and used for 24 hour treatment. Then, catalase (CAT), glutathione (GSH), glutathione peroxidase (GPX), glutathione reductase (GR) activities and Malondialdehyde (MDA) levels were assayed in the cell lysate.

Results: The results of the present study indicated that EST, PRO, and their combination were strongly able to increase the antioxidant enzymes activity compared with controls and significantly decreased the MDA levels in all three cell lines.

Conclusion: The data suggest that female sex hormones and OCPs might exert antioxidant effects in different cancerous organs.

Keywords: Oxidative Stress, Estrogen, Progesterone, Antioxidant Enzymes, Female Cancers

References:

[1] Bellanti, F., Matteo, M., Rollo, T., De Rosario, F., Greco, P., Vendemiale, G. & Serviddio, G. (2013) Sex hormones modulate circulating antioxidant enzymes: Impact of estrogen therapy(), Redox Biology. 1, 340-346.

[2] Javed, S., Ali, M., Ali, F., Anwar, S. S. & Wajid, N. (2015) Status of oxidative stress in breast cancer patients in Pakistani population, Advancements in Life Sciences. 2, 115-118.

[3] Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. (2010) Oxidative stress, inflammation, and cancer: How are they linked?, Free radical biology & medicine. 49, 1603-1616.

[4] Kazemi, E., Mortazavi, S. M., Ali-Ghanbari, A., Sharifzadeh, S., Ranjbaran, R., Mostafavi-Pour, Z., Zal, F. & Haghani, M. (2015) Effect of 900 MHz Electromagnetic Radiation on the Induction of ROS in Human Peripheral Blood Mononuclear Cells, J Biomed Phys Eng. 5, 105-14.

[5] Sosa, V., Moline, T., Somoza, R., Paciucci, R., Kondoh, H. & ME, L. L. (2013) Oxidative stress and cancer: an overview, Ageing research reviews. 12, 376-90.

[6] Yaghutian Nezhad, L., Mohseni Kouchesfahani, H., Alaee, S., Bakhtari, A. J. H. & Toxicology, E. (2021) Thymoquinone ameliorates bleomycin-induced reproductive toxicity in male Balb/c mice. 40, S611-S621.

[7] Burdon, R. H., Gill, V. & Rice-Evans, C. (1989) Cell proliferation and oxidative stress, Free radical research communications. 7, 149-59.

[8] Bakhtari, A., Nazari, S., Alaee, S., Kargar-Abarghouei, E., Mesbah, F., Mirzaei, E., Molaei, M. J. J. I. J. o. F. & Sterility (2020) Effects of dextran-coated superparamagnetic iron oxide nanoparticles on mouse embryo development, antioxidant enzymes and apoptosis genes expression, and ultrastructure of sperm, oocytes and granulosa cells. 14, 161.

[9] Moradi Sarabi, M., Ghareghani, P., Khademi, F. & Zal, F. (2017) Oral Contraceptive Use May Modulate Global Genomic DNA Methylation and Promoter Methylation of APC1 and ESR1, Asian Pac J Cancer Prev. 18, 2361- 2366.

[10] Ahuja, M. & Pujari, P. (2017) Ultra-low-dose oral contraceptive pill: a new approach to a conventional requirement, International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 6, 364-370.

[11] Bao, P. P., Shu, X. O., Gao, Y. T., Zheng, Y., Cai, H., Deming, S. L., Ruan, Z. X., Su, Y., Gu, K., Lu, W. & Zheng, W. (2011) Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study, American journal of epidemiology. 174, 661-71.

[12] Tam, B. K., E., W. C., A., K. N., Janet, T., Jason, A. & Kathy, T. (2013) Oral contraceptive use in women at increased risk of breast/ovarian cancer: knowledge and attitudes, Psycho-Oncology. 22, 228-232.

[13] IARC, I. (1987) monographs on the evaluation of carcinogenic risks to humans: overall evaluations of carcinogenicity: an updating of IARC monographs vol. 1–42, No. Supplement 7, International agency for research on cancer.

[14] Fallah, S., Sani, F. V. & Firoozrai, M. (2011) Effect of contraceptive pills on the activity status of the antioxidant enzymes glutathione peroxidase and superoxide dismutase in healthy subjects, Contraception. 83, 385-389.

[15] Izzo, F., Mercogliano, F., Venturutti, L., Tkach, M., Inurrigarro, G., Schillaci, R., Cerchietti, L., Elizalde, P. V. & Proietti, C. J. (2014) Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased protein turnover promoting breast tumor growth, Breast Cancer Research. 16, 491.

[16] Ehsanpour, S., Nejad, F. S. A., Rajabi, F. M. & Taleghani, F. (2013) Investigation on the association between breast cancer and consumption patterns of combined oral contraceptive pills in the women of Isfahan in 2011, Iranian journal of nursing and midwifery research. 18, 186.

[17] Ishihara, Y., Takemoto, T., Ishida, A. & Yamazaki, T. (2015) Protective actions of 17β-estradiol and progesterone on oxidative neuronal injury induced by organometallic compounds, Oxidative medicine and cellular longevity. 2015.

[18] Zal, F., Khademi, F., Taheri, R. & Mostafavi-Pour, Z. (2018) Antioxidant ameliorating effects against H2O2-induced cytotoxicity in primary endometrial cells, Toxicol Mech Methods. 28, 122-129.

[19] Fecondo, J. V. & Augusteyn, R. C. (1983) Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens, Experimental eye research. 36, 15-23.

[20] Mostafavi–Pour, Z., Zal, F., Monabati, A. & Vessal, M. (2008) Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats, Hepatology Research. 38, 385-392.

[21] Zal, F., Taheri, R., Khademi, F., Keshavarz, E., Rajabi, S. & Mostafavi-Pour, Z. (2014) The combined effect of furosemide and propranolol on GSH homeostasis in ACHN renal cells, Toxicol Mech Methods. 24, 412-6.

[22] Ellman, G. L. (1959) Tissue sulfhydryl groups, Archives of biochemistry and biophysics. 82, 70-77.

[23] Sardarian, A., Andisheh Tadbir, A., Zal, F., Amini, F., Jafarian, A., Khademi, F. & Mostafavi-Pour, Z. (2015) Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells, Toxicol Mech Methods. 25, 98-104.

[24] Aebi, H. (1984)

[13] Catalase in vitro, Methods in enzymology. 105, 121-126.

[25] Placer, Z. A., Cushman, L. L. & Johnson, B. C. (1966) Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems, Analytical biochemistry. 16, 359-364.

[26] Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem. 72, 248-54.

[27] Daniels, K. & Mosher, W. D. (2013) Contraceptive methods women have ever used: United States, 1982-2010, National health statistics reports, 1-15.

[28] Zal, F., Miladpour, B., Taheri, R., Heidari, I. & Mostafavi-Pour, Z. (2015) Estrogen and/or Progesterone Effects on HepG2 Human Cell Lines; Oxidant or Antioxidant?, Journal of Advanced Medical Sciences and Applied Technologies. 1, 35-41.

[29] Escalante, C. G., Mora, S. Q. & Bolaños, L. N. (2017) Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens’ cardioprotective effect through atherosclerosis prevention, Journal of mid-life health. 8, 11.

[30] Chang, S. H., Chang, C.-H., Yang, M. C., Hsu, W. T., Hsieh, C. Y., Hung, Y. T., Su, W. L., Shiu, J. J., Huang, C. Y. & Liu, J. Y. (2015) Effects of estrogen on glutathione and catalase levels in human erythrocyte during menstrual cycle, Biomedical reports. 3, 266-268.

[31] Bednarek-Tupikowska, G., Bohdanowicz-Pawlak, A., Bidzińska, B., Milewicz, A., Antonowicz-Juchniewicz, J. & Andrzejak, R. (2001) Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women, Gynecological Endocrinology. 15, 298-303.

[32] Girotti, A. W. (1998) Lipid hydroperoxide generation, turnover, and effector action in biological systems, Journal of lipid research. 39, 1529-1542.

[33] Tang, M., Abplanalp, W., Ayres, S. & Subbiah, M. R. (1996) Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation, Metabolism. 45, 411-414.

[34] Ray, P. D., Huang, B.-W. & Tsuji, Y. (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cellular signalling. 24, 981-990.

[35] Delijewski, M., Beberok, A., Otręba, M., Wrześniok, D., Rok, J. & Buszman, E. (2014) Effect of nicotine on melanogenesis and antioxidant status in HEMn-LP melanocytes, Environmental research. 134, 309-314.

[36] Sobočanec, S., Šarić, A., Šafranko, Ž. M., Hadžija, M. P., Abramić, M. & Balog, T. (2015) The role of 17β-estradiol in the regulation of antioxidant enzymes via the Nrf2–Keap1 pathway in the livers of CBA/H mice, Life sciences. 130, 57-65.

[37] Atla, B., Sarkar, R. N. & Rasaputra, M. (2016) Clinicopathological and IHC study (estrogen receptors, progesterone receptor, HER2/NEU) in malignant ovarian tumors, International Journal of Research in Medical Sciences. 4, 1068-1073.

[38] Borrás, C., Gambini, J., Gómez-Cabrera, M. C., Sastre, J., Pallardó, F. V., Mann, G. E. & Viña, J. (2005) 17β-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2 [MAPK]/NFκB cascade, Aging cell. 4, 113-118.

[39] Borrás, C., Gambini, J., López-Grueso, R., Pallardó, F. V. & Viña, J. (2010) Direct antioxidant and protective effect of estradiol on isolated mitochondria, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802, 205-211.

[40] Goyal, M. M. & Basak, A. (2010) Human catalase: looking for complete identity, Protein & cell. 1, 888-897.

Download
HTML
Cite
Share
statistics

0 Abstract Views

PDF Downloads